Enhancing neutralizing antibody production by an interferon-inducing porcine reproductive and respiratory syndrome virus strain

Vaccine

Volumn 31, Issue 47, 2013, Pages 5537-5543

  Wang, Rong ^a   Xiao, Yueqiang ^a,b   Opriessnig, Tanja ^c   Ding, Yi ^a   Yu, Ying ^a   Nan, Yuchen ^a   Ma, Zexu ^a   Halbur, Patrick G ^c   Zhang, Yan Jin ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b Shandong Binzhou Animal Science and Veterinary Medicine Academy   (China)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

IFN inducing A2MC2; Neutralizing antibody; Porcine reproductive and respiratory syndrome virus; PRRSV

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; SWINE; VIRUS STRAIN; VIRUS VIRULENCE;

IFN-INDUCING A2MC2.; NEUTRALIZING ANTIBODY; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRRSV;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; INJECTIONS, INTRAMUSCULAR; INTERFERONS; LUNG; MACROPHAGES; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 84886768394     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.023     Document Type: Article

References (35)

1. Holtkamp D.J., Kliebenstein J.B., Neumann E.J., Zimmerman J.J., Rotto H.F., Yoder T.K., et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J Swine Health Prod 2013, 21:72-84.
2. Faaberg K.S., Balasuriya U.B., Brinton M.A., Gorbalenya A.E., Leung F.C.-C., Nauwynck H., et al. Family Arteriviridae. Virus Taxonomy Ninth Report of the International Committee on Taxonomy of Viruses. 2011, Elsevier Academic Press;, London. A.M.Q. King (Ed.).
3. Kim H.S., Kwang J., Yoon I.J., Joo H.S., Frey M.L. Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line. Arch Virol 1993, 133:477-483.
4. Rossow K.D., Collins J.E., Goyal S.M., Nelson E.A., Christopher Hennings J., Benfield D.A. Pathogenesis of porcine reproductive and respiratory syndrome virus infection in gnotobiotic pigs. Vet Pathol 1995, 32:361-373.
5. Labarque G.G., Nauwynck H.J., Van Reeth K., Pensaert M.B. Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs. J Gen Virol 2000, 81:1327-1334.
6. Xiao Z., Batista L., Dee S., Halbur P., Murtaugh M.P. The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. J Virol 2004, 78:5923-5933.
7. Albina E., Carrat C., Charley B. Interferon-alpha response to swine arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. J Interferon Cytokine Res 1998, 18:485-490.
8. Miller L.C., Laegreid W.W., Bono J.L., Chitko-McKown C.G., Fox J.M. Interferon type I response in porcine reproductive and respiratory syndrome virus-infected MARC-145 cells. Arch Virol 2004, 149:2453-2463.
9. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cellular Microbiol 2006, 8:907-922.
10. Botner A., Strandbygaard B., Sorensen K.J., Have P., Madsen K.G., Madsen E.S., et al. Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet Rec 1997, 141:497-499.
11. Sorensen K.J., Botner A., Madsen E.S., Strandbygaard B., Nielsen J. Evaluation of a blocking Elisa for screening of antibodies against porcine reproductive and respiratory syndrome (PRRS) virus. Vet Microbiol 1997, 56:1-8.
12. Opriessnig T., Halbur P.G., Yoon K.J., Pogranichniy R.M., Harmon K.M., Evans R., et al. Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV. J Virol 2002, 76:11837-11844.
13. Madsen K.G., Hansen C.M., Madsen E.S., Strandbygaard B., Botner A., Sorensen K.J. Sequence analysis of porcine reproductive and respiratory syndrome virus of the American type collected from Danish swine herds. Arch Virol 1998, 143:1683-1700.
14. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet Microbiol 2000, 74:309-329.
15. Osorio F.A., Galeota J.A., Nelson E., Brodersen B., Doster A., Wills R., et al. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology 2002, 302:9-20.
16. Lopez O.J., Oliveira M.F., Garcia E.A., Kwon B.J., Doster A., Osorio F.A. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin Vaccine Immunol 2007, 14:269-275.
17. Nan Y., Wang R., Shen M., Faaberg K.S., Samal S.K., Zhang Y.J. Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology 2012, 432:261-270.
18. Meng X.J., Paul P.S., Halbur P.G., Lum M.A. Characterization of a high-virulence US isolate of porcine reproductive and respiratory syndrome virus in a continuous cell line, ATCC CRL11171. J Vet Diagn Invest 1996, 8:374-381.
19. Benfield D.A., Nelson E., Collins J.E., Harris L., Goyal S.M., Robison D., et al. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J Vet Diagn Invest 1992, 4:127-133.
20. Zhang Y.J., Stein D.A., Fan S.M., Wang K.Y., Kroeker A.D., Meng X.J., et al. Suppression of porcine reproductive and respiratory syndrome virus replication by morpholino antisense oligomers. Vet Microbiol 2006, 117:117-129.
21. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995, 32:648-660.
22. Halbur P.G., Paul P.S., Meng X.J., Lum M.A., Andrews J.J., Rathje J.A. Comparative pathogenicity of nine US porcine reproductive and respiratory syndrome virus (PRRSV) isolates in a five-week-old cesarean-derived, colostrum-deprived pig model. J Vet Diagn Invest 1996, 8:11-20.
23. Patel D., Stein D.A., Zhang Y.J. Morpholino oligomer-mediated protection of porcine pulmonary alveolar macrophages from arterivirus-induced cell death. Antivir Ther 2009, 14:899-909.
24. Van Nieuwstadt A.P., Meulenberg J.J.M., Essen-Zandbergen A., Besten A.P., Bende R.J., Moormann R.J.M., et al. Proteins encoded by open reading frames 3 and 4 of the genome of Lelystad virus (Arteriviridae) are structural proteins of the virion. J Virol 1996, 70:4767-4772.
25. Zhang Y., Sharma R.D., Paul P.S. Monoclonal antibodies against conformationally dependent epitopes on porcine reproductive and respiratory syndrome virus. Vet Microbiol 1998, 63:125-136.
26. Patel D., Opriessnig T., Stein D.A., Halbur P.G., Meng X.J., Iversen P.L., et al. Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication. Antiviral Res 2008, 77:95-107.
27. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
28. Said E.A., Dupuy F.P., Trautmann L., Zhang Y.W., Shi Y., El-Far M., et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection. Nat Med 2010, 16. 452-U136.
29. Mukaida N., Harada A., Yasumoto K., Matsushima K. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol 1992, 36:773-789.
30. Bassaganya-Riera J., Thacker B.J., Yu S., Strait E., Wannemuehler M.J., Thacker E.L. Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells. Viral Immunol 2004, 17:25-37.
31. Darwich L., Diaz I., Mateu E. Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology. Virus Res 2010, 154:123-132.
32. Vanhee M., Van Breedam W., Costers S., Geldhof M., Noppe Y., Nauwynck H. Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies. Vaccine 2011, 29:4794-4804.
33. Gonin P., Pirzadeh B., Gagnon C.A., Dea S. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. J Vet Diagn Invest 1999, 11:20-26.
34. Weiland E., Wieczorek-Krohmer M., Kohl D., Conzelmann K.K., Weiland F. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet Microbiol 1999, 66:171-186.
35. Meulenberg J.J.M., Nieuwstadt APv, Essen Zandbergen Av, Langeveld J.P.M., Van Nieuwstadt A.P., Van Essen Zandbergen A. Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus. J Virol 1997, 71:6061-6067.